Cresset Asset Management, LLC Arcturus Therapeutics Holdings Inc. Transaction History
Cresset Asset Management, LLC
- $17.3 Billion
- Q4 2024
A detailed history of Cresset Asset Management, LLC transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Cresset Asset Management, LLC holds 11,511 shares of ARCT stock, worth $140,088. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,511
Previous 13,709
16.03%
Holding current value
$140,088
Previous $318,000
38.68%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding ARCT
# of Institutions
164Shares Held
26MCall Options Held
163KPut Options Held
173K-
Federated Hermes, Inc. Pittsburgh, PA4.69MShares$57.1 Million0.19% of portfolio
-
Black Rock Inc. New York, NY2.65MShares$32.2 Million0.0% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.2.07MShares$25.1 Million0.02% of portfolio
-
Nikko Asset Management Americas, Inc.2.07MShares$25.1 Million0.39% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl1.93MShares$23.5 Million0.29% of portfolio
About Arcturus Therapeutics Holdings Inc.
- Ticker ARCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,576,400
- Market Cap $323M
- Description
- Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...